<p>SK-HEP1 liver cancer cells were treated with (at 0.5 mg/ml) or without AcFBE for 2 or 4 hrs. Immunoblotting experiments were repeated twice using GAPDH or Tubulin as controls. The duplicates were averaged and shown below each protein band, and the phosphorylated-to-unphosphorylated ratios were then calculated and shown below the treated samples. Protein bands were from the first set of immunoblotting experiment. The normalized protein level of untreated samples was set as 1.00 for comparing to their corresponding AcFBE-treated samples. 2U, untreated for 2 hrs; 2T, treated for 2 hrs; 4U, untreated for 4 hrs; 4T, treated for 4 hrs.</p
<p>HepG2 cells were treated with 50 μM of PI3K ((LY294002), p38 (SB202190) or JNK (SP600125) inhibit...
<p>Panels A and B show the data from one of two Western blots using control cells or cells treated w...
<p>Total NF-κB was used as an internal control. β actin was used as an internal control. Each column...
<p>Cells were pre-treated with NO-Cbl (300 µM, 16 h) followed by doxorubicin (20 µM, 4 h) or cisplat...
<p>The lysates of liver tissues (A) and BRL cells (B) from <a href="http://www.plosone.org/article/i...
<p>(<b>A</b>) HepG2 cells were treated with 2.5 µM AFB1 for 1, 3, or 5 days, or treated with 1, 2.5,...
<p>(A) Representative panels of p-EGFR, total-EGFR, p-Akt, total-Akt, and p-PKCα proteins in IPEC-J2...
<p>•<b>) as determined by Western blotting.</b> A representative immunoblot of p-Akt<sup>T308</sup> ...
<p>Western blot analysis of pAkt and Akt in non-differentiated (St-T1, first line; KdS1, second line...
<p>Cells were pre-treated for 90 min with different concentrations of UA (70,100, 120 μM) and then t...
<p>Representative immunoblots displayed. Data quantitated as ratio of phosphorylated JNK to total JN...
<p><b>A:</b> Caco-2 cells were treated with varying concentrations of IAP and sodium orthovanadate. ...
<p>A549 cells were untreated or treated with 500 nM of 1, 9, 12, 16, 32, 33, and 35 for 24 h. Follow...
<p>All transcriptomes were analyzed with RNA-Seq approach. The expression level of an mRNA is repres...
<p>Cells were pre-treated for 90 min with different concentrations of CA (20, 50, 70 μM) and then tr...
<p>HepG2 cells were treated with 50 μM of PI3K ((LY294002), p38 (SB202190) or JNK (SP600125) inhibit...
<p>Panels A and B show the data from one of two Western blots using control cells or cells treated w...
<p>Total NF-κB was used as an internal control. β actin was used as an internal control. Each column...
<p>Cells were pre-treated with NO-Cbl (300 µM, 16 h) followed by doxorubicin (20 µM, 4 h) or cisplat...
<p>The lysates of liver tissues (A) and BRL cells (B) from <a href="http://www.plosone.org/article/i...
<p>(<b>A</b>) HepG2 cells were treated with 2.5 µM AFB1 for 1, 3, or 5 days, or treated with 1, 2.5,...
<p>(A) Representative panels of p-EGFR, total-EGFR, p-Akt, total-Akt, and p-PKCα proteins in IPEC-J2...
<p>•<b>) as determined by Western blotting.</b> A representative immunoblot of p-Akt<sup>T308</sup> ...
<p>Western blot analysis of pAkt and Akt in non-differentiated (St-T1, first line; KdS1, second line...
<p>Cells were pre-treated for 90 min with different concentrations of UA (70,100, 120 μM) and then t...
<p>Representative immunoblots displayed. Data quantitated as ratio of phosphorylated JNK to total JN...
<p><b>A:</b> Caco-2 cells were treated with varying concentrations of IAP and sodium orthovanadate. ...
<p>A549 cells were untreated or treated with 500 nM of 1, 9, 12, 16, 32, 33, and 35 for 24 h. Follow...
<p>All transcriptomes were analyzed with RNA-Seq approach. The expression level of an mRNA is repres...
<p>Cells were pre-treated for 90 min with different concentrations of CA (20, 50, 70 μM) and then tr...
<p>HepG2 cells were treated with 50 μM of PI3K ((LY294002), p38 (SB202190) or JNK (SP600125) inhibit...
<p>Panels A and B show the data from one of two Western blots using control cells or cells treated w...
<p>Total NF-κB was used as an internal control. β actin was used as an internal control. Each column...